TOP NEWS: Dr Martens shares plunge on revenue caution and US warning

(Alliance News) - Dr Martens PLC on Thursday reported a drop in its half-year earnings, said it ...

Alliance News 30 November, 2023 | 9:22AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - Dr Martens PLC on Thursday reported a drop in its half-year earnings, said it expects lower full-year revenue and added that a recovery in the key US market will take than it first expected.

Shares in Dr Martens slumped 25% to 86.20 pence each in London on Thursday morning.

The Northamptonshire, England-based boot manufacturer said in the half-year ended September 30, pretax profit fell by 55% to GBP25.8 million from GBP57.9 million the year before.

Earnings before interest, tax, depreciation and amortisation fell 13% to GBP77.6 million from GBP88.8 million a year prior.

Revenue declined 5.4% to GBP395.8 million from GBP418.8 million the year before. Its top line was hurt by "an increasingly difficult consumer environment" in the US.

Dr Martens maintained its interim dividend at 1.56 pence per share.

Chief Executive Officer Kenny Wilson commented: "We saw a mixed trading performance in the first half of the year. We made good progress with our strategic priorities, continuing to invest in the business and our people to drive sustainable long-term growth. During the period we focused on controlling the controllables: we delivered significant supply chain savings, successfully transformed our North America distribution network, opened 25 new stores, and launched a Dr Martens UK repair service."

Looking ahead, the company said it remains confident in its long-term growth prospects and its "cash generative nature". Nevertheless, it said it expects full year revenue to decline by a high single-digit percentage, on a constant currency basis.

It also said it expects financial 2024 Ebitda to be "moderately below the bottom end of the range of consensus expectations" of GBP223.7 million to GBP240.0 million.

In financial 2023, it achieved an Ebitda of GBP245.0 million and revenue of GBP1.00 billion.

Dr Martens also added that pretax profit for the year will be hurt by higher net finance costs of around GBP5 million.

Dr Martens cautioned that a bounce in its US division will take longer to materialise than initially anticipated.

"We have strengthened the Americas leadership team and they are taking action, including refocusing marketing and improving our ecommerce trading capabilities. It is likely, however, that given the challenging backdrop it will take longer to see an improvement in USA results than initially anticipated. Notwithstanding the clear challenges we face in the USA market we remain very confident in our iconic brand and the significant growth opportunity ahead of us," added CEO Wilson.

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Dr. Martens PLC Ordinary Shares 96.75 GBX 1.74 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures